Yahoo Finance, via GlobalData, reports on NVIDIA championing the Innophore partnership to model drug dynamics with artificial intelligence. The CavitOmiX AI platform is designed to predict hidden side effects and discover new therapeutic uses for existing drugs by analyzing the three-dimensional properties of protein binding sites. The coverage in one of the world’s most widely read financial news outlets reflects the growing investor and industry interest in AI-driven approaches to pharmaceutical research and development.